477 related articles for article (PubMed ID: 30662405)
61. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
62. The Mevalonate Pathway Is Indispensable for Adipocyte Survival.
Yeh YS; Jheng HF; Iwase M; Kim M; Mohri S; Kwon J; Kawarasaki S; Li Y; Takahashi H; Ara T; Nomura W; Kawada T; Goto T
iScience; 2018 Nov; 9():175-191. PubMed ID: 30396151
[TBL] [Abstract][Full Text] [Related]
63. Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.
Ogura S; Yoshida Y; Kurahashi T; Egawa M; Furuta K; Kiso S; Kamada Y; Hikita H; Eguchi H; Ogita H; Doki Y; Mori M; Tatsumi T; Takehara T
Oncotarget; 2018 Apr; 9(30):21022-21035. PubMed ID: 29765517
[TBL] [Abstract][Full Text] [Related]
64. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain.
Sever N; Yang T; Brown MS; Goldstein JL; DeBose-Boyd RA
Mol Cell; 2003 Jan; 11(1):25-33. PubMed ID: 12535518
[TBL] [Abstract][Full Text] [Related]
65. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
66. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.
Hussein D; Mo H
Pancreas; 2009 May; 38(4):e124-36. PubMed ID: 19346993
[TBL] [Abstract][Full Text] [Related]
67. Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.
Mendoza-Oliva A; Ferrera P; Fragoso-Medina J; Arias C
CNS Neurosci Ther; 2015 Aug; 21(8):631-41. PubMed ID: 26096465
[TBL] [Abstract][Full Text] [Related]
68. Dysregulation of the mevalonate pathway promotes transformation.
Clendening JW; Pandyra A; Boutros PC; El Ghamrasni S; Khosravi F; Trentin GA; Martirosyan A; Hakem A; Hakem R; Jurisica I; Penn LZ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15051-6. PubMed ID: 20696928
[TBL] [Abstract][Full Text] [Related]
69. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
[TBL] [Abstract][Full Text] [Related]
70. d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells.
Fernandes NV; Guntipalli PK; Mo H
Anticancer Res; 2010 Dec; 30(12):4937-44. PubMed ID: 21187473
[TBL] [Abstract][Full Text] [Related]
71. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
72. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
[TBL] [Abstract][Full Text] [Related]
73. HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival.
Lacher SM; Bruttger J; Kalt B; Berthelet J; Rajalingam K; Wörtge S; Waisman A
Cell Death Dis; 2017 May; 8(5):e2824. PubMed ID: 28542128
[TBL] [Abstract][Full Text] [Related]
74. Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with
Jo Y; Kim SS; Garland K; Fuentes I; DiCarlo LM; Ellis JL; Fu X; Booth SL; Evers BM; DeBose-Boyd RA
Elife; 2020 Mar; 9():. PubMed ID: 32118581
[TBL] [Abstract][Full Text] [Related]
75. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
76. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
[TBL] [Abstract][Full Text] [Related]
77. Statins: a role in breast cancer therapy?
Borgquist S; Bjarnadottir O; Kimbung S; Ahern TP
J Intern Med; 2018 Oct; 284(4):346-357. PubMed ID: 29923256
[TBL] [Abstract][Full Text] [Related]
78. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.
Kita T; Brown MS; Goldstein JL
J Clin Invest; 1980 Nov; 66(5):1094-100. PubMed ID: 6903572
[TBL] [Abstract][Full Text] [Related]
79. Matrix metalloproteinase-2 mediates a mechanism of metabolic cardioprotection consisting of negative regulation of the sterol regulatory element-binding protein-2/3-hydroxy-3-methylglutaryl-CoA reductase pathway in the heart.
Wang X; Berry E; Hernandez-Anzaldo S; Takawale A; Kassiri Z; Fernandez-Patron C
Hypertension; 2015 Apr; 65(4):882-8. PubMed ID: 25646300
[TBL] [Abstract][Full Text] [Related]
80. Pleiotropic effects of statins.
Kavalipati N; Shah J; Ramakrishan A; Vasnawala H
Indian J Endocrinol Metab; 2015; 19(5):554-62. PubMed ID: 26425463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
